Brii Biosciences

Brii Biosciences is an innovative drug research and development service provider dedicated to advancing therapies for major infectious diseases (such as hepatitis B virus (HBV), human immunodeficiency virus (HIV), multidrug-resistant (MDR) or extensively drug-resistant (XDR) Gram-negative bacterial infections) and other diseases with significant public health burdens (such as central nervous system (CNS) diseases). We strive to redefine the therapeutic landscape by applying extraordinarily bold ideas, making substantial and unique contributions to science and health.